Postoperative lung injury after lung cancer resection is still a difficult problem to be solved. Thrombomodulin (TM) is a membrane-bound glycoprotein of endothelial cells, and its serum level is elevated in patients with acute lung injury or acute respiratory distress syndrome. In fact, TM is abundant in the pulmonary capillary vessels. Lung resection reduces the volume of pulmonary capillary vessels; however, the change in the serum levels of TM after lung resection remains to be investigated. We therefore analyzed the postoperative changes in the serum TM levels in 60 patients who underwent thoracotomy without lung resection (n = 3), partial resection of the lung (n = 15), or lobectomy (n = 42). Preoperative and postoperative day-1 laboratory data including the serum levels of TM and KL-6, a sialylated carbohydrate antigen (a biomarker for pulmonary fibrosis), and oxygenation index were collected. Unexpectedly, the postoperative serum levels of TM were lower than preoperative values in lobectomy group, whereas they remained unchanged after thoracotomy without lung resection and after partial resection of the lung. In addition, the serum TM level decreased proportional to the resected lung volume. Eight out of 42 patients with lobectomy presented high postoperative serum levels of TM, and 3 out of these 8 patients presented postoperative impaired oxygenation. Postoperative impaired oxygenation occurred only in patients with elevated TM levels; namely, an increase of serum TM is associated with impaired oxygenation after lung resection. In conclusion, serum TM is a possible biomarker for predicting the occurrence of postoperative lung injury.
devices, and postoperative management have increased the safety of patients undergoing lung cancer resection. The postoperative 30-day mortality rate for lung cancer patients is reportedly 0.4 -0.6% in Japan (Watanabe et al. 2004; Sakata et al. 2010 ), but lung resection occasionally leads to postoperative acute lung injury or acute respiratory distress syndrome (ALI/ARDS), including acute exacerbation of pulmonary fibrosis (Ruffini et al. 2001; Dulu et al. 2006; Alam et al. 2007; Chida et al. 2008; Tang et al. 2008; Saito et al. 2011) . The American College of Chest Physicians (ACCP) evidence-based clinical practice guideline (Colice et al. 2007) indicates the patients at increased risk for postoperative mortality or morbidity after lung cancer resection based on physiological evaluation. However, it does not identify a specific patient who is going to develop postoperative ALI/ARDS. Previous studies have suggested that age, extensive resection, poor respiratory function, excessive perioperative transfusion, and low predicted postoperative diffusion capacity are risk factors for postoperative ALI/ ARDS (Ruffini et al. 2001; Dulu et al. 2006; Alam et al. 2007; Tang et al. 2008) . Recently, Japanese researchers reported that acute exacerbation of idiopathic pulmonary fibrosis, one of the postoperative ALI/ARDS, was associated with a preoperative subclinical fibrotic change (Chida et al. 2008; Saito et al. 2011 ). Yet, it remains difficult for us to predict the occurrence of postoperative ALI/ARDS in the early postoperative phase.
Thrombomodulin (TM) is a membrane-bound glycoprotein that is important for maintaining the anticoagulative properties of the endothelium (Esmon and Owen 1981) . TM expression is widely observed in highly vascularized organs such as the kidney and lung in mice (Ford et al. 1992) . The interface of the pulmonary capillary endothelium and alveolar epithelium serves as a site for blood-gas exchange, where anticoagulation is necessary. The endothelial cells in early developing human lungs do not express TM. However, as the lungs mature and the number of cap-illary endothelial cells around the lung buds increase, they begin to express TM (Maeda et al. 2002) . TM is essential for the pulmonary capillary endothelium to establish functional blood-gas exchange (Maeda et al. 2002) .
TM has been utilized as a biomarker of endothelial cell injury in vitro and ex vivo Sawada et al. 1992; Miyazaki et al. 1998; Boehme et al. 2002) . Many studies have shown elevated levels of serum TM among patients with disseminated intravascular coagulopathy, diabetes mellitus, systemic lupus erythematosus, and a variety of collagen-vascular diseases (Takano et al. 1990; Tanaka et al. 1991; Wada et al. 1993; Ohdama et al. 1994 ). Serum TM is also elevated in patients with sepsis (Hack and Zeerleder 2001; van der Poll et al. 2005) , ALI/ARDS (Cone et al. 2003; Terada et al. 2003; Ware et al. 2003; Gando et al. 2004) , and acute exacerbation of pulmonary fibrosis (Collard et al. 2010) . Moreover, elevated serum TM has been observed in patients undergoing esophagogastrectomy (Reid et al. 2000) . To the best of our knowledge, however, there has been no detailed report on changes in serum TM after lung resection, nor the potential use of serum TM as a biomarker for postoperative lung injury in association with oxygenation index.
We conducted a serial prospective observational study to determine postoperative changes in serum TM associated with the resected lung volume and oxygenation index. Our initial hypothesis was that serum TM would increase after a major lung resection such as lobectomy because of the lung injury related with surgery. However, most of the patients who underwent lobectomy had decreased serum levels of TM. Our results indicate that the serum level of TM decreases after lobectomy proportionally to the ratio of unresected lung segments. Based on this new finding, we suggest that serum TM is a possible biomarker for postoperative lung injury after lung resection.
Patients and Methods

Patients
The subjects of this study included 60 consecutive patients who underwent general thoracic surgery between October 2006 and March 2007 at the Department of Thoracic Surgery, Miyagi Cancer Center. They had not received chemotherapy and radiotherapy before their operation. This study was approved by the Ethical Committee for Human Research at Miyagi Cancer Center, and all patients provided their informed consent to participate in the study. Each patient was anesthetized and placed in a lateral position with the affected side upward. The trachea was intubated with a double lumen tube for differential ventilation during surgery. The patients underwent one of the following surgical procedures, thoracotomy without lung resection (thoracotomy group), partial resection of the lung (partial resection group), or lobectomy including pneumonectomy (lobectomy group). On postoperative day 1 (POD1), all patients were administered oxygen at 1-3 L/min via a nasal cannula.
Collection of Clinical Data
Clinical data collected in this study included: smoking history, height, weight, body surface area, operation time, volume of fluid transfusion, blood loss, blood transfusion during surgery, and lung perfusion percentage on the affected side. The number of resected lung segments was counted when the patients underwent a lobectomy; for example: left upper lobectomy, 5 segments (the left S 1+2 was regarded as 2 segments); left lower lobectomy, 4 segments.
The patients underwent a lung function test for physiological evaluation before surgery. Vital capacity (VC), forced VC (FVC), forced expiratory volume in one second (FEV 1.0 ), and diffusion lung capacity for carbon monoxide (D LCO ) were measured with a FUDAC-70 spirometer (Fukuda Denshi Co. Ltd., Japan). Predicted postoperative (ppo) FEV 1.0 and D LCO were calculated according to the ACCP evidence-based clinical practice guideline (Colice et al. 2007) .
Chest computed tomography (CT) was performed with highresolution CT within the month preceding surgery. CT images were obtained using 5.0-2.5 mm sections. According to the previous studies (Chida et al. 2008; Saito et al. 2011) , honeycomb formation, reticular shadow, and ground-glass opacity were considered as the features of pulmonary fibrosis on CT images.
Blood was analyzed 1-2 days before surgery (preoperative) and on POD1 (postoperative) with a Coulter LH 750 analyzer (Beckman Coulter, Inc., USA) to determine the complete blood count and white cell differential, and an ARCHITECT c8000 analyzer (Toshiba Medical Systems Corporation, Japan) to determine laboratory data including lactic dehydrogenase (LDH) and C-reactive peptide (CRP) levels. The serum levels of TM and sialylated carbohydrate antigen KL-6 (KL-6) were measured by SRL Inc. (Tokyo, Japan). Arterial blood gas was measured on the same day with a Siemens Rapidlab 860 analyzer (Siemens Healthcare Diagnostics Inc., USA).
Predicted postoperative serum levels of KL-6 and TM
Serum KL-6 originates from type II alveolar epithelial cells in peripheral lung tissue (Kohno et al. 1989 ). The serum level of KL-6 after lung resection is decreased proportionally to the residual lung segments (Sakuma et al. 1999) . TM is widely expressed in the pulmonary capillary endothelial cells in adult lungs (Maeda et al. 2002) . We therefore supposed that the serum level of TM would be associated with the volume of the pulmonary capillary vessels as that of KL-6 was associated with the volume of peripheral lung tissues. The predicted postoperative serum levels KL-6 and TM were calculated on the basis of the number of resected lung segments using the following formula: predicted postoperative serum level of KL-6 (or TM) = preoperative value of KL-6 (or TM) × (total segments − resected segments) / total segments (Sakuma et al. 1999) . We compared the predicted postoperative serum levels of KL-6 and TM with actual postoperative values.
Oxygenation index
The oxygenation index was calculated on the assumption that FiO 2 was 0.24 when patients were administrated oxygen at 1 L/min via a nasal cannula, 0.28 at 2 L/min, and 0.32 at 3 L/min. The formula used was as follows: Oxygenation index = PaO 2 / FiO 2 .
Data analysis and statistics
All data are presented as mean ± s.d. Data among the groups were compared using a one-factor analysis of variance (ANOVA). Values at different time points for each patient were compared using a paired t-test. Predicted and actual postoperative serum levels of KL-6 and TM were subjected to correlation analysis and simple regression analysis. We used StatView for Windows ver. 5.0.1 (SAS Institute Inc) for the analyses, and statistical significance was defined as P ≤ 0.05.
Results
Patient characteristics
Patient characteristics are summarized in Table 1 . There were three patients in thoracotomy group, 15 in partial resection group, and 42 in lobectomy group. All patients in lobectomy group had sufficient lung function (%ppo FEV1.0 > 40 and %ppo DLCO > 40; data not shown) and they were considered to be at average risk for lung resection (Colice et al. 2007 ).
Preoperative and actual postoperative serum levels of TM
Preoperative and actual postoperative serum levels of TM for each patient are plotted in Fig. 1 . Mean preoperative and actual postoperative serum levels of TM (FU/mL) were 3.5 ± 0.4 and 3.6 ± 0.3 in thoracotomy group, 2.9 ± 0.7 and 2.7 ± 0.5 in partial resection group, and 2.9 ± 0.7 and 2.5 ± 0.6 in lobectomy group, respectively. Except for three patients in lobectomy group, all serum TM data were within the reference ranges. These three exceptions were a 69-year-old male with severe diabetes mellitus, severe systemic arthrosclerosis, and features of interstitial pulmonary fibrosis on his CT images, a 68-year-old male with severe diabetes mellitus and rheumatoid arthritis, and a 69-yearold female with pernicious anemia because of Vitamin B12 deficiency caused by anti-gastric wall antibody.
Preoperative serum levels of TM were not significantly different among three groups (P = 0.2752; ANOVA). The actual postoperative serum level of TM was significantly lower than the preoperative level in the lobectomy group (P < 0.0001; paired t-test), but no significant differences were observed in thoracotomy and partial resection groups (P = 0.6914 and P = 0.1868; paired t-test). There were eight patients in lobectomy group (indicated with bold lines in Fig. 1 ) who had an increased actual postoperative serum level of TM compared with each preoperative level.
Correlations between predicted and actual postoperative serum levels of KL-6 and TM in lobectomy group
Preoperative, predicted, and actual postoperative serum levels of KL-6 and TM in lobectomy group are shown in Table 2 . Smoking status and interstitial pulmonary fibrotic changes on CT did not impact preoperative and actual postoperative serum levels of KL-6 and TM (data not shown). There was a significant difference between preoperative and actual postoperative serum levels of KL-6 (P < 0.0001; paired t-test) and between preoperative and predicted postoperative serum levels of KL-6 (P < 0.0001; paired t-test). However, no significant difference between predicted and actual postoperative serum levels of KL-6 was observed (P = 0.4508; paired t-test). A strong correlation (R 2 = 0.822) was found between predicted and actual postoperative serum levels of KL-6 in the lobectomy group (Fig. 2) .
Regarding serum TM, there was a significant difference between preoperative and predicted postoperative, preoperative and actual postoperative, and predicted and actual postoperative serum levels of TM (Table 2 ). There was a small but significant increase in actual postoperative serum levels of TM compared with predicted postoperative values (P = 0.0002; paired t-test, Table 2 ). As with serum KL-6, a strong correlation (R 2 = 0.616) was observed between predicted and actual postoperative serum levels of TM (Fig. 2) .
Relationship between oxygenation index and the serum level of TM in lobectomy group
The preoperative oxygenation index for each patient in the lobectomy group was higher than 300 (range, 330-515; mean ± s.d., 409.8 ± 51.2). The postoperative oxygenation index ranged from 253 to 638 (mean ±s.d., 464.2 ± 82.0). The postoperative oxygenation index was significantly higher than the preoperative value (P < 0.0001; paired t-test). However, three patients presented with impaired oxygenation, i.e., oxygenation index of ≤ 350. These three patients arose from eight patients who had increased postoperative serum levels of TM compared with preoperative values ( Fig.1 and Table 3 ). In other words, the actual postoperative serum levels of TM among these eight patients were increased by > 0.5 KU/mL compared with their predicted postoperative values (Table 3) .
Discussion
Our results are summarized as follows: first of all, the serum level of TM decreased after lobectomy, but remained unchanged after thoracotomy without lung resection and partial resection of the lung; secondary, the actual postoperative serum level of TM was strongly correlated with the predicted postoperative value which was calculated according to the ratio of unresected lung segments after lobectomy, as with serum KL-6; finally, patients with postoperative impaired oxygenation had increased serum levels of TM after lobectomy. It was noteworthy that the actual postoperative serum levels of TM were all within the refer- Graphs showing the preoperative and actual postoperative (POD1) levels of serum TM in the thoracotomy (left), partial resection (centre), and lobectomy groups (right). There was no significant difference in the preoperative serum levels of TM among the three groups (ANOVA). Nor was there any difference between the two time points in the thoracotomy and partial resection groups (paired t-test). In contrast, the actual postoperative serum level of TM was significantly smaller than the preoperative values in the lobectomy group (P < 0.0001; paired t-test). POD1, postoperative day 1; TM, thrombomodulin. ence ranges in this study; however, patients with impaired oxygenation had highly increased postoperative serum levels of TM compared with predicted values. These results suggest that a postoperative increase relative to the predicted level of TM is important for predicting impaired oxygenation after lung resection. Serum TM is used as a biomarker of endothelial cell injury. In vitro and ex vivo studies have shown that endothelial injury decreases TM expression in the endothelium and increases the level of TM in culture or perfusion media Sawada et al. 1992; Miyazaki et al. 1998; Boehme et al. 2002) . These results indicate that TM is shed because of injury and that soluble TM is released into the surrounding media. Neutrophil elastase is the enzyme most likely to be responsible for shedding TM because a previous study demonstrated that serum levels of neutrophil elastase and serum TM both increased after surgery (Reid et al. 2000) . Therefore, we initially hypothesized that the serum level of TM would increase after lobectomy because of the lung injury caused by surgery. Interestingly, we found the opposite, i.e., the serum level of TM decreased after lobectomy.
To explain this surprising result, we showed that serum levels of KL-6 decreased proportionally to the ratio of unresected lung segments after lobectomy. The actual postoperative serum level of KL-6 was strongly correlated with the predicted postoperative serum level of KL-6, and these were almost equivalent. Findings from other studies support this result (Sakuma et al. 1999) , especially soon after lung resection such as on POD1. The biological source of serum KL-6 is the type II alveolar epithelium (Kohno et al. 1989) ; therefore, serum KL-6 originates from the peripheral lung tissue. Lobectomy reduces the volume of the peripheral lung tissue according to the ratio of unresected lung Fig. 2 . Correlations between the predicted and actual postoperative serum levels of KL-6 and TM.
Graphs presenting correlations between the predicted and actual postoperative (POD1) serum levels of KL-6 (left) and TM (right). Strong correlations were identified between predicted and actual postoperative (POD1) serum levels of both KL-6 and TM. Open triangle, 5 patients with increased serum level of TM, without impaired oxygenation on POD1; open square, 3 patients with increased serum level of TM and impaired oxygenation on POD1. segments. Thus, we were able to predict the postoperative serum level of KL-6 by calculation.
The relationship between the volume of the peripheral lung tissue and the serum level of KL-6 was applicable to the case of serum TM. The former study demonstrated that TM is widely expressed in the pulmonary capillary endothelial cells (Maeda et al. 2002) in the peripheral lung tissue. Our study presented that loss of the peripheral lung tissue leads to a decrease in serum TM. The strong correlation between the actual and predicted postoperative serum levels of TM is also supportive. The only difference in the findings for serum KL-6 and serum TM is that the actual postoperative serum level of TM was slightly greater than the predicted postoperative value. If serum TM originated only from pulmonary endothelial cells and there was little injury to these cells, the predicted postoperative serum level would be the same as the actual postoperative value as with serum KL-6. However, serum TM originated from nonpulmonary endothelial cells as well. Presumably there would be a baseline level of serum TM remaining unchanged after lung resection. This could explain the small increase in the actual postoperative serum level of TM compared with the predicted postoperative value observed here. Another reason could be that the pulmonary endothelial cells were slightly but actually damaged by lobectomy. It is possible that both explanations are reasonable.
Another study group showed that levels of TM are increased in the plasma and at a greater magnitude in the edema fluid among patients with ALI/ARDS (Ware et al. 2003) . They demonstrated that A549 cells released soluble TM in response to injurious stimuli in vitro, and suggested that alveolar epithelial type II cells are the source of TM in the edema fluid of patients with ALI/ARDS (Ware et al. 2003) . Even if alveolar epithelial type II cells were a major source of serum TM, our finding that serum levels of TM decreased after lobectomy could be explained by the loss of the peripheral lung tissue. Moreover, the small increase in the actual postoperative serum level of TM compared with the predicted postoperative value could also be explained by pulmonary endothelial cell injury. Further investigation for the question how much serum TM originates from pulmonary endothelial cells and alveolar type II cells under normal conditions is required to clarify our results.
Our findings also raise another question: does lung resection cause endothelial damage and a subsequent increase in serum levels of TM, resulting in impaired oxygenation postoperatively, or does lung resection cause impaired oxygenation, resulting in endothelial damage and an increase in serum levels of TM? We found that all patients with impaired postoperative oxygenation had highly elevated serum levels of TM compared with predicted levels. Based on this result, we consider that lung resection leads lung injury and pulmonary endothelial damage and that some patients suffer impaired oxygenation if the injury is extensive enough to alter the oxygenation status.
There were several limitations to the current study. First, we have limited data from just two time points, preoperative and postoperative, on POD1. Second, there was no incidence of ALI/ARDS as defined by the consensus definition (Bernard et al. 1994 ) after lung resection. Postoperative chest X-rays of the patients appeared minimally changed, and there was no abnormal finding such as diffuse infiltration or regional atelectasis. Because previous reports from Japanese researchers have indicated that the incidence of postoperative ARDS is 1.3%~2.0% after lung resection (Chida et al. 2008; Saito et al. 2011) , the 42 lobectomy patients included here may not be enough to observe any ALI/ARDS. In addition, postoperative impaired oxygenation might occur for reasons other than postoperative lung injury such as increased pulmonary shunt volume and ventilation-perfusion mismatch. Moreover, the oxygenation index was calculated using assumed values of FiO 2 . The true FiO 2 value would be smaller than assumed, and this may have led us to underestimate the oxygenation index values.
In summary, our study demonstrated that the serum level of TM decreased after lung resection proportionally to the ratio of unresected lung segments. Based on this novel finding, serum TM would be a possible biomarker to predict postoperative lung injury in the early postoperative phase. This study suggests that a target of postoperative lung injury is the pulmonary endothelium, and protection or restoration of TM on endothelium is a possible approach for preventing postoperative ALI/ARDS.
